Abstracts Archive - Page 1971 of 2605 - ACR Meeting Abstracts

Abstract Number: 1526 • 2015 ACR/ARHP Annual Meeting
Employment and Quality of Life Among Patients with Rheumatoid Arhtritis in Four Latin-American Countries
Ricardo Xavier^1,2, Fernando Chalem³, Javier Duhau⁴, Jorge Morales^5,6, Cesar Ramos-Remus⁷, Jose Fernando Molina⁸, Eugenia Carnide⁹ and Annette Perez-Gilbe¹⁰, ¹Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil, ²RUA ATILIO BILIBIO, 120 CASA 9, Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil, ³Fundación Instituto de Reumatología Fernando Chalem, Bogota, Colombia, ⁴Centro de Investigaciones en Enfermedades Reumáticas (CIER), Buenos Aires, Argentina, ⁵Imagenology X ray, Hospital de Especialidades Centro Medico La Raza IMSS, Mexico, Mexico, ⁶Rheumatology, Hospital Aranda de la Parra, Leon, Mexico, ⁷Unidad de Investigacion en Enf. Cronico-Degenerativas, Guadalajara, Mexico, ⁸Reumalab, Medellín, Colombia, ⁹Abbvie Inc, São Paulo, Brazil, ¹⁰Abbvie Inc, San Juan
Background/Purpose: Rheumatoid Arthritis impacts negatively on quality of life and work productivity. There are virtually no data on the employment status and burden of disease…
Abstract Number: 1527 • 2015 ACR/ARHP Annual Meeting
Serum Inflammation Identifies Increased Risk of Frailty in Rheumatoid Arthritis
James S. Andrews¹, Elizabeth R. Wahl², Gabriela Schmajuk³, Edward H. Yelin⁴ and Patricia P. Katz⁵, ¹Rheumatology, University of California San Francisco, San Francisco, CA, ²Medicine/Rheumatology, San Francisco Veterans Affairs Medical Center, San Francisco, CA, ³San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA, ⁴University of California, San Francisco, San Francisco, CA, ⁵Rheumatology, UCSF, SF, CA
Background/Purpose: Frailty has been defined as “an excess vulnerability to stressors, with reduced ability to maintain or regain homeostasis after a destabilizing event” 1. Frailty…
Abstract Number: 1528 • 2015 ACR/ARHP Annual Meeting
Predictors of Employment, Work Productivity Loss, Activity Impairment, and Regaining Employment in Latinos with Rheumatoid Arthritis in the United States
George A. Karpouzas¹, Taylor Draper², Elizabeth Hernandez³, Rosalinda Moran³ and Sarah Ormseth³, ¹Harbor UCLA Med Ctr, Torrance, CA, ²Cousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA, ³Rheumatology, Harbor-UCLA Medical Center, Torrance, CA
Background/Purpose: Patients with Rheumatoid arthritis (RA) experience declining functional ability, quality of life, employment and work productivity. Such outcomes have been described in homogeneous, mostly…
Abstract Number: 1529 • 2015 ACR/ARHP Annual Meeting
Trabecular Bone Score in Early Rheumatoid Arthritis
Eulalia Armengol¹, Helena Borrell Paños¹, Joan Miquel Nolla¹, Javier Narváez² and Carmen Gomez Vaquero¹, ¹Department of Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ²Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain
Background/Purpose: Rheumatoid Arthritis (RA) is associated with low bone mass and increased risk of fragility fractures that are related to patient characteristics, treatments and disease…
Abstract Number: 1530 • 2015 ACR/ARHP Annual Meeting
Neutrophil Function and Survival Unaffected in Healthy Subjects Following Single Administration of Tocilizumab
Laurence Lok¹, Jatinder Juss¹, Neda Farahi¹, Chrystalla Loutsios¹, Chandra Solanki², Adrien Michael Peters³, Sophie Dimonaco⁴, Francis Donaldson⁴, Benjamin Porter-Brown⁴ and Edwin Chilvers¹, ¹Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom, ²Department of Nuclear Medicine, Cambridge University Hospitals, Cambridge, United Kingdom, ³Division of Clinical and Laboratory Investigation, Brighton and Sussex Medical School, Brighton, United Kingdom, ⁴Roche Products Ltd., Welwyn Garden City, United Kingdom
Background/Purpose: Decreases in circulating neutrophil counts have been observed in adults with rheumatoid arthritis (RA) and children with systemic or polyarticular juvenile idiopathic arthritis treated…
Abstract Number: 1531 • 2015 ACR/ARHP Annual Meeting
The Changing Face of Septic Arthritis Complicating Rheumatoid Arthritis in the Era of Biotherapies. Retrospective Single-Center Study over 35 Years
Jean-Jacques Dubost¹, Bruno Pereira², Anne Tournadre³, Zuzana Tatar¹, Marion Couderc¹ and Martin Soubrier¹, ¹Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France, ²Biostatistics unit (DRCI), CHU Clermont-Ferrand, Clermont-Ferrand, France, ³Rheumatology, UNH-UMR 1019 INRA University of Auvergne and Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France
Background/Purpose: Rheumatoid arthritis (RA) is a risk factor for septic arthritis (SA), and anti-TNF therapy doubles the risk of SA. The purpose of this study…
Abstract Number: 1532 • 2015 ACR/ARHP Annual Meeting
Occurrence of Valvular Heart Disease in Rheumatoid Arthritis: A Population Based Study
Tamanna Khullar¹, John P. Bois¹, Cynthia S. Crowson², Megan L. Krause³ and Rekha Mankad¹, ¹Cardiovascular Diseases, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic, Rochester, MN, ³Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: Patients with rheumatoid arthritis (RA) are known to have an increased risk of cardiovascular disease, particularly atherosclerosis and heart failure. However, little is known…
Abstract Number: 1533 • 2015 ACR/ARHP Annual Meeting
Age Related Disability in Daily Life Should be Considered in Older Than Sixty-Five-Year-Old Rheumatoid Arthritis Patient
Ichiro Yoshii¹ and Tatsumi Chijiwa², ¹Department of Orthopaedic Surgery, Yoshii Hospital, Shimanto, Japan, ²Rheumatology, Kochi Memorial Hospital, Kochi, Japan
Background/Purpose: In treating rheumatoid arthritis (RA), patient’s activity in daily life (ADL) is extremely important factor, because RA is chronic inflammatory disease that leads discomfort…
Abstract Number: 1534 • 2015 ACR/ARHP Annual Meeting
Temporal Trends and Outcomes of Acute Myocardial Infarction in Rheumatoid Arthritis Hospitalizations
Narender Annapureddy¹, Achint Patel², Rabi Yacoub³, Krishna Pakanati⁴, Shiv Agarwal⁵, Priya Simoes⁶, Shaan Patel³, Sunil Kamat⁷, Alexandre Benjo⁸ and Girish Nadkarni⁹, ¹Rheumatology and Immunology, Vanderbilt University, Nashville, TN, ²Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, ³Icahn School of Medicine at Mount Sinai, New York, NY, ⁴Gateway Medical Center, Clarksville, TN, ⁵Cardiology, University of Arkansas Medical Sciences, Little Rock, AR, ⁶Internal Medicine, St.Lukes Roosevelt Hospital Center at Mount Sinai, New York, NY, ⁷Critical Care, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India, ⁸Ochsner Clinic Foundation, New Orleans, NY, ⁹Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY
Background/Purpose: Rheumatoid arthritis (RA) is associated with increased risk of cardiac mortality. With better treatment modalities, some studies suggest that infarction (AMI) mortality in RA…
Abstract Number: 1535 • 2015 ACR/ARHP Annual Meeting
The Clinical Impact of Overweight in Rheumatoid Arthritis Patients: Comparison Between Korean and Other Countries within the Comora Study
Kichul Shin¹, Eun Young Ahn², Hyun Mi Kwon², In Ah Choi³, Yeonsoo Baik⁴ and Yeong Wook Song², ¹Division of Rheumatology, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea, ²Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, ³Division of Rheumatology, Department of internal medicine, Chungbook National University Hospital, Cheongju-si, South Korea, ⁴Division of Rheumatology, Department of internal medicine, SMG-SNU Boramae Medical Center, Seoul, South Korea
Background/Purpose: Obesity has recently been spotlighted as an important comorbidity in rheumatoid arthritis (RA); not only associated with disease severity but also its development. Despite…
Abstract Number: 1536 • 2015 ACR/ARHP Annual Meeting
Sensorineural Hearing Impairment and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients without Traditional Cardiovascular Risk Factors
Hector Macias Reyes¹, Sergio Duran-Barragan^2,3, Cynthia Cardenas Contreras⁴, Cesar Chavez Martin⁴, Eduardo Gomez², Rosa Navarro Hernandez², Jorge Aguilar Arreola^2,5, Paul Perez-Cruz^2,5, Carlos Yanowsky Gonzalez² and Monica Vazquez-Del Mercado^2,5, ¹1. Hospital Civil Fray Antonio Alcalde, Guadalajara, Mexico, ²Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Instituto de Investigación en Reumatología y del Sistema Musculoesquelético, Guadalajara, Mexico, ³Clinica de Investigación en Reumatología y Obesidad, Guadalajara, Mexico, ⁴Hospital Civil Fray Antonio Alcalde, Guadalajara, Mexico, ⁵Servicio de Reumatología, División de Medicina Interna, Hospital Civil Dr. Juan I. Menchaca, Guadalajara, Mexico
Background/Purpose: Rheumatoid arthritis (RA) is characterized by inflammation of the synovial membrane of the diarthrodial joints which include arthrodesis of the middle ear, (incudomalleolar and…
Abstract Number: 1537 • 2015 ACR/ARHP Annual Meeting
Effect of TNF-Alpha Blockade on Body Composition in Inflammatory Rheumatic Disease: Systematic Review with Meta-Analysis
sarah marouen¹, Thomas Barnetche², Bernard Combe³, Jacques Morel⁴ and Claire I. Daien⁴, ¹Rhumatology Department, Lapeyronie Hospital and Montpellier University, Montpellier, France, ²Rheumatology Department, Pellegrin University Hospital, BORDEAUX, France, ³Rheumatology, Hopital Lapeyronie, Montpellier, France, ⁴Department of rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France
Background/Purpose: Patients with chronic inflammatory rheumatic disease have elevated circulating concentrations of TNF-alpha and other pro-inflammatory cytokines that can modify body composition. Metabolic changes are…
Abstract Number: 1538 • 2015 ACR/ARHP Annual Meeting
Clinical Analysis of 30 Rheumatoid Arthritis Patients Complicated with Malignant Lymphoma, Especially Methotrexate-Related Lymphoproliferative Disorder
Takuma Tsuzuki Wada¹, Yuji Akiyama¹ and Toshihide Mimura², ¹Department of Rheumatology & Applied Immunology, Faculty of Medicine, Saitama Medical University, Iruma, Japan, ²Department of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Saitama, Japan
Background/Purpose: Recently, methotrexate (MTX) has been considered as the anchor drug in the treatment of rheumatoid arthritis (RA). However, it has been reported that MTX…
Abstract Number: 1539 • 2015 ACR/ARHP Annual Meeting
Control of Modifiable Cardiovascular Risk Factors in Rheumatoid Arthritis Patients Compared to Traditional High-Risk Cardiovascular Disease Patients
Brian LaMoreaux¹, Alexa Meara² and Wael N. Jarjour³, ¹Rheumatology, The Ohio State University, Columbus, OH, ²Internal Medicine/Rheumatology, The Ohio State University, Columbus, OH, ³Department of Internal Medicine, Division of Immunology and Rheumatology, The Ohio State University Medical Center, Columbus, OH
Background/Purpose: Rheumatoid arthritis (RA) is a chronic systemic inflammatory autoimmune disease affecting one percent of the population. The main cause of mortality among RA patients…
Abstract Number: 1540 • 2015 ACR/ARHP Annual Meeting
Cardiovascular Risk Management in Rheumatoid Arthritis Patients
Calin Popa¹, Elke.E.A. Arts¹, Inger L. Meek¹, Frank H.J. van den Hoogen² and Jaap Fransen¹, ¹Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ²Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands
Background/Purpose: Rheumatoid arthritis (RA) patients have been previously shown to have a higher cardiovascular (CV) burden as compared to the general population. The CV risk…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].